文献速递神经肿瘤神经重症

软脑膜转移的脑脊液分流:姑息、手术与肿瘤学结局

Cerebrospinal fluid diversion for leptomeningeal metastasis: palliative, procedural and oncologic outcomes.
PubMed 文献 · J Neurooncol · 2021-08-18

分流后总生存自LM诊断起为4.14个月(95%CI:3.29-4.70),自分流起为2.43个月(95%CI:2.01-3.09);分流时KPS与LM诊断时脑转移数目与生存显著相关。

要点

  • 分流时KPS较高与生存改善相关(HR=0.66,95%CI 0.51-0.86,p=0.002)。
  • LM诊断时每增加10个脑转移灶与生存相关(HR=1.40,95%CI 1.01-1.93,p=0.04)。

核心结论

  • 对有脑积水和颅内高压的软脑膜转移患者,脑脊液分流可实现症状缓解、出院并回归进一步肿瘤治疗。
  • 鉴于预后有限,决策须结合临终关怀目标。

主要发现

  • 自LM诊断起总生存4.14个月(95%CI:3.29-4.70),自分流起2.43个月(95%CI:2.01-3.09)。
  • 分流时KPS与生存显著相关(HR=0.66;95%CI 0.51-0.86,p=0.002)。
  • LM诊断时脑转移数目与生存显著相关(每10个BrM:HR=1.40;95%CI 1.01-1.93,p=0.04)。
  • 分流后56%患者接受额外系统治疗或开始/完成WBRT。

关键数值与推荐

  • 并发症:感染5%、症状性硬膜下积液/血肿6.3%、分流管外置/移除/修补8%。
  • 未发现腹部种植转移。

临床怎么用

  • 对LM继发脑积水和颅内高压患者可行CSF分流以缓解症状并为后续肿瘤治疗创造条件。
  • 分流决策应结合KPS、脑转移负荷及临终关怀目标个体化评估。

局限性

  • 为单中心回顾性研究,可能存在选择偏倚,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Leptomeningeal metastasis (LM) occurs in 3-5% of patients with solid metastatic tumors and often portends a severe prognosis including symptomatic hydrocephalus and intracranial hypertension. Cerebrospinal fluid (CSF) shunting can provide symptomatic relief in this patient subset; however, few studies have examined the role of shunting in the palliation, prognosis and overall oncologic care of these patients. OBJECTIVE: To identify and evaluate risk factors associated with prognosis after CSF diversion and assess surgical, symptomatic and oncologic outcomes in this population. METHODS: A retrospective study was conducted on patients with solid-malignancy LM treated with a shunt at a NCI-designated Comprehensive Cancer Center between 2010 and 2019. RESULTS: One hundred and ninety patients with metastatic LM underwent CSF diversion. Overall survival was 4.14 months from LM diagnosis (95% CI: 3.29-4.70) and 2.43 months (95% CI: 2.01-3.09) from shunting. Karnofsky performance status (KPS) at time of shunting and brain metastases (BrM) number at LM diagnosis demonstrated significant associations with survival (HR = 0.66; 95% CI [0.51-0.86], p = 0.002; HR = 1.40; 95% CI [1.01-1.93] per 10 BrM, p = 0.04, respectively). Eighty-three percent of patients experienced symptomatic relief, and 79% were discharged home or to rehabilitation facilities post-shunting. Post-shunt, 56% of patients received additional systemic therapy or started or completed WBRT. Complications included infection (5%), symptomatic subdural hygroma/hematoma (6.3%), and shunt externalization/removal/repair (8%). Abdominal seeding was not identified. CONCLUSIONS: CSF diversion for LM with hydrocephalus and intracranial hypertension secondary to metastasis can achieve symptomatic relief, hospital discharge, and return to further oncologic therapy, with a complication profile unique to this pathophysiology. However, decision-making in this population must incorporate end-of-life goals of care given limited prognosis.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Bander ED, Yuan M, Reiner AS, et al. Cerebrospinal fluid diversion for leptomeningeal metastasis: palliative, procedural and oncologic outcomes. J Neurooncol. 2021. PMID: 34406564. doi:10.1007/s11060-021-03827-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。